Wang Baojin
No ORCID on file
· 22 papers in corpus
· active 2004-2020
Study types
- article 1
- review 1
Condition tags
- adenomyosis 2
- endometriosis 1
Top journals
Frequent coauthors
- Wu Huazhen 20
- Zhao Xuan 20
- Huang Guanyou 11
- Liu Zhiqiang 10
- Shaochong Lin 1
- Junpeng Du 1
- Wenhui Yang 1
- Xi-Ling Fu 1
- Xinyue Wang 1
- Xuan Zhao 1
review
2020
Review question / Objective: The aim of the systematic review and meta-analysis is to evaluate the efficacy and safety of dienogest in the treatment of women with symptoms ascribed to endometriosis or adenomyosis. Condition being studied: E…
2004
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
article
2004
2004
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
2004
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
2004
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
2004
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
2004
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
2004
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
2004
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
2004
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
2004
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
2004
An ELISA method was established by using transferrin as coating antigen to detect the serum samples from 38 female with endometriosis (20 cases with stage I-II, 9 cases with stage III, 9 cases with stage IV), 30 benign lesions, 40 normal fe…
2004
An ELISA method was established by using transferrin as coating antigen to detect the serum samples from 38 female with endometriosis (20 cases with stage I-II, 9 cases with stage III, 9 cases with stage IV), 30 benign lesions, 40 normal fe…
2004
An ELISA method was established by using transferrin as coating antigen to detect the serum samples from 38 female with endometriosis (20 cases with stage I-II, 9 cases with stage III, 9 cases with stage IV), 30 benign lesions, 40 normal fe…
2004
An ELISA method was established by using transferrin as coating antigen to detect the serum samples from 38 female with endometriosis (20 cases with stage I-II, 9 cases with stage III, 9 cases with stage IV), 30 benign lesions, 40 normal fe…
2004
An ELISA method was established by using transferrin as coating antigen to detect the serum samples from 38 female with endometriosis (20 cases with stage I-II, 9 cases with stage III, 9 cases with stage IV), 30 benign lesions, 40 normal fe…
2004
An ELISA method was established by using transferrin as coating antigen to detect the serum samples from 38 female with endometriosis (20 cases with stage I-II, 9 cases with stage III, 9 cases with stage IV), 30 benign lesions, 40 normal fe…
2004
An ELISA method was established by using transferrin as coating antigen to detect the serum samples from 38 female with endometriosis (20 cases with stage I-II, 9 cases with stage III, 9 cases with stage IV), 30 benign lesions, 40 normal fe…
2004
An ELISA method was established by using transferrin as coating antigen to detect the serum samples from 38 female with endometriosis (20 cases with stage I-II, 9 cases with stage III, 9 cases with stage IV), 30 benign lesions, 40 normal fe…
2004
An ELISA method was established by using transferrin as coating antigen to detect the serum samples from 38 female with endometriosis (20 cases with stage I-II, 9 cases with stage III, 9 cases with stage IV), 30 benign lesions, 40 normal fe…
2004
An ELISA method was established by using transferrin as coating antigen to detect the serum samples from 38 female with endometriosis (20 cases with stage I-II, 9 cases with stage III, 9 cases with stage IV), 30 benign lesions, 40 normal fe…